1-3 of 3
Daniel J Coleman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Transcriptional Reprogramming of Super-Enhancer Associated Oncogenes Following Inhibition of Cyclin-Dependent Kinase-9 (CDK9) in Aggressive Non-Hodgkin Lymphoma (NHL)

Elana Thieme, Duanchen Sun, Geeta G Sharma, Nur Bruss, Tingting Liu, Daniel J Coleman, Zheng Xia, Alexey V. Danilov
Journal: Blood
Blood (2021) 138 (Supplement 1): 3493.
https://doi.org/10.1182/blood-2021-149725
Published: 2021
Journal Articles

FLT3 and LSD1 Inhibitor Combinations Synergistically Repress Growth of FLT3-Mutant Acute Myeloid Leukemia Via Blockage of MYC Function

Daniel J. Coleman, PhD, Brittany M. Smith, Cody Coblentz, Rowan L. Callahan, Jake VanCampen, Garth L. Kong, Brian J. Druker, MD, Julia E. Maxson, PhD, Theodore P. Braun, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 31–32.
https://doi.org/10.1182/blood-2020-143029
Published: 2020
Journal Articles

Oncogenic SETBP1 Mutations Combine with Activating Mutations in CSF3R to Produce a Highly Proliferative, Lethal Leukemia through Aberrant Myc Signaling

Sarah A Carratt, PhD BS, Theodore P. Braun, MDPhD, Zachary Schonrock, BS, Brittany M. Smith, Daniel J Coleman, PhD, Garth Kong, MS, Joseph Estabrook, MS, Adrian Baris, Lauren Maloney, Julia E. Maxson, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 51–52.
https://doi.org/10.1182/blood-2020-143072
Published: 2020